Research programme: cell membrane modulators - BioLine Rx

Drug Profile

Research programme: cell membrane modulators - BioLine Rx

Alternative Names: BL N020; BL-2060

Latest Information Update: 13 Mar 2009

Price : $50

At a glance

  • Originator BioLineRx
  • Class
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 28 Oct 2008 Preclinical trials in Bacterial infections in Israel (Inhalation)
  • 28 Oct 2008 Preclinical pharmacodynamics data presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America (ICAAC/IDSA-2008)
  • 16 Nov 2006 Preclinical trials in Bacterial infections in Israel (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top